Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Amortization of Deferred Charges (2019 - 2020)

Neurogene (NGNE) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $253000.0 as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Amortization of Deferred Charges rose 954.17% year-over-year to $253000.0, compared with a TTM value of $808000.0 through Sep 2020, changed N/A, and an annual FY2014 reading of $320000.0, up 2185.71% over the prior year.
  • Amortization of Deferred Charges was $253000.0 for Q3 2020 at Neurogene, up from $3000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $528000.0 in Q1 2020 and bottomed at $3000.0 in Q2 2020.